TIGIT and neoplasm: Additive and/or synergistic effects after co-engagement of TIGIT and FcγRIIIA in NK cells with tumor cells suggest that several NK activatory pathways (such as DANM-1 and FcγRIIIA) may converge downstream, leading to stronger signals.